{
    "2023-03-31": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.4,
        "Normalized EBITDA": -123300000.0,
        "Total Unusual Items": -4000000.0,
        "Total Unusual Items Excluding Goodwill": -4000000.0,
        "Net Income From Continuing Operation Net Minority Interest": -175400000.0,
        "Reconciled Depreciation": 23700000.0,
        "Reconciled Cost Of Revenue": 357400000.0,
        "EBIT": -147000000.0,
        "Net Interest Income": -7600000.0,
        "Interest Expense": 7600000.0,
        "Normalized Income": -175400000.0,
        "Net Income From Continuing And Discontinued Operation": -175400000.0,
        "Total Expenses": 466500000.0,
        "Total Operating Income As Reported": 49900000.0,
        "Diluted Average Shares": 67984496.0,
        "Basic Average Shares": 67984496.0,
        "Diluted EPS": -2.58,
        "Basic EPS": -2.58,
        "Diluted NI Availto Com Stockholders": -175400000.0,
        "Net Income Common Stockholders": -175400000.0,
        "Net Income": -175400000.0,
        "Minority Interests": -900000.0,
        "Net Income Including Noncontrolling Interests": -174500000.0,
        "Net Income Continuous Operations": -174500000.0,
        "Tax Provision": 19900000.0,
        "Pretax Income": -154600000.0,
        "Other Income Expense": -196900000.0,
        "Other Non Operating Income Expenses": -196900000.0,
        "Special Income Charges": -7700000.0,
        "Gain On Sale Of Business": -7700000.0,
        "Gain On Sale Of Security": 3700000.0,
        "Net Non Operating Interest Income Expense": -7600000.0,
        "Interest Expense Non Operating": 7600000.0,
        "Operating Income": 49900000.0,
        "Operating Expense": 109100000.0,
        "Other Operating Expenses": NaN,
        "Research And Development": 6200000.0,
        "Selling General And Administration": 102900000.0,
        "Gross Profit": 159000000.0,
        "Cost Of Revenue": 357400000.0,
        "Total Revenue": 516400000.0,
        "Operating Revenue": 516400000.0
    },
    "2022-12-31": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.4,
        "Normalized EBITDA": 73100000.0,
        "Total Unusual Items": -500000.0,
        "Total Unusual Items Excluding Goodwill": -500000.0,
        "Net Income From Continuing Operation Net Minority Interest": 8500000.0,
        "Reconciled Depreciation": 39300000.0,
        "Reconciled Cost Of Revenue": 367200000.0,
        "EBIT": 33800000.0,
        "Net Interest Income": -7800000.0,
        "Interest Expense": 7800000.0,
        "Normalized Income": 8500000.0,
        "Net Income From Continuing And Discontinued Operation": 8500000.0,
        "Total Expenses": 507000000.0,
        "Total Operating Income As Reported": 50000000.0,
        "Diluted Average Shares": 68124000.0,
        "Basic Average Shares": 67793000.0,
        "Diluted EPS": 0.12,
        "Basic EPS": 0.13,
        "Diluted NI Availto Com Stockholders": 8500000.0,
        "Net Income Common Stockholders": 8500000.0,
        "Net Income": 8500000.0,
        "Minority Interests": -300000.0,
        "Net Income Including Noncontrolling Interests": 8800000.0,
        "Net Income Continuous Operations": 8800000.0,
        "Tax Provision": 17200000.0,
        "Pretax Income": 26000000.0,
        "Other Income Expense": -16200000.0,
        "Other Non Operating Income Expenses": -16200000.0,
        "Special Income Charges": NaN,
        "Gain On Sale Of Business": NaN,
        "Gain On Sale Of Security": -500000.0,
        "Net Non Operating Interest Income Expense": -7800000.0,
        "Interest Expense Non Operating": 7800000.0,
        "Operating Income": 50000000.0,
        "Operating Expense": 139800000.0,
        "Other Operating Expenses": 5000000.0,
        "Research And Development": 6900000.0,
        "Selling General And Administration": 132900000.0,
        "Gross Profit": 189800000.0,
        "Cost Of Revenue": 367200000.0,
        "Total Revenue": 557000000.0,
        "Operating Revenue": 557000000.0
    },
    "2022-09-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.4,
        "Normalized EBITDA": -31300000.0,
        "Total Unusual Items": -5900000.0,
        "Total Unusual Items Excluding Goodwill": -5900000.0,
        "Net Income From Continuing Operation Net Minority Interest": -40100000.0,
        "Reconciled Depreciation": 25600000.0,
        "Reconciled Cost Of Revenue": 356900000.0,
        "EBIT": -31300000.0,
        "Net Interest Income": -7900000.0,
        "Interest Expense": 7900000.0,
        "Normalized Income": -40100000.0,
        "Net Income From Continuing And Discontinued Operation": -40100000.0,
        "Total Expenses": 469200000.0,
        "Total Operating Income As Reported": -8000000.0,
        "Diluted Average Shares": 67787000.0,
        "Basic Average Shares": 67787000.0,
        "Diluted EPS": -0.59,
        "Basic EPS": -0.59,
        "Diluted NI Availto Com Stockholders": -40100000.0,
        "Net Income Common Stockholders": -40100000.0,
        "Net Income": -40100000.0,
        "Minority Interests": -200000.0,
        "Net Income Including Noncontrolling Interests": -39900000.0,
        "Net Income Continuous Operations": -39900000.0,
        "Tax Provision": 700000.0,
        "Pretax Income": -39200000.0,
        "Other Income Expense": -23300000.0,
        "Other Non Operating Income Expenses": -23300000.0,
        "Special Income Charges": NaN,
        "Gain On Sale Of Business": NaN,
        "Gain On Sale Of Security": -5900000.0,
        "Net Non Operating Interest Income Expense": -7900000.0,
        "Interest Expense Non Operating": 7900000.0,
        "Operating Income": -8000000.0,
        "Operating Expense": 112300000.0,
        "Other Operating Expenses": 6500000.0,
        "Research And Development": 6000000.0,
        "Selling General And Administration": 106300000.0,
        "Gross Profit": 104300000.0,
        "Cost Of Revenue": 356900000.0,
        "Total Revenue": 461200000.0,
        "Operating Revenue": 461200000.0
    },
    "2022-06-30": {
        "Tax Effect Of Unusual Items": -1040000.0,
        "Tax Rate For Calcs": 0.4,
        "Normalized EBITDA": 39900000.0,
        "Total Unusual Items": -2600000.0,
        "Total Unusual Items Excluding Goodwill": -2600000.0,
        "Net Income From Continuing Operation Net Minority Interest": -17100000.0,
        "Reconciled Depreciation": 25500000.0,
        "Reconciled Cost Of Revenue": 366900000.0,
        "EBIT": 11800000.0,
        "Net Interest Income": -8300000.0,
        "Interest Expense": 8300000.0,
        "Normalized Income": -15540000.0,
        "Net Income From Continuing And Discontinued Operation": -17100000.0,
        "Total Expenses": 488700000.0,
        "Total Operating Income As Reported": 33700000.0,
        "Diluted Average Shares": 67694000.0,
        "Basic Average Shares": 67694000.0,
        "Diluted EPS": -0.25,
        "Basic EPS": -0.25,
        "Diluted NI Availto Com Stockholders": -17100000.0,
        "Net Income Common Stockholders": -17100000.0,
        "Net Income": -17100000.0,
        "Minority Interests": -300000.0,
        "Net Income Including Noncontrolling Interests": -16800000.0,
        "Net Income Continuous Operations": -16800000.0,
        "Tax Provision": 20300000.0,
        "Pretax Income": 3500000.0,
        "Other Income Expense": -14500000.0,
        "Other Non Operating Income Expenses": -11900000.0,
        "Special Income Charges": NaN,
        "Gain On Sale Of Business": NaN,
        "Gain On Sale Of Security": -2600000.0,
        "Net Non Operating Interest Income Expense": -8300000.0,
        "Interest Expense Non Operating": 8300000.0,
        "Operating Income": 26300000.0,
        "Operating Expense": 121800000.0,
        "Other Operating Expenses": 7400000.0,
        "Research And Development": 4800000.0,
        "Selling General And Administration": 109600000.0,
        "Gross Profit": 148100000.0,
        "Cost Of Revenue": 366900000.0,
        "Total Revenue": 515000000.0,
        "Operating Revenue": 515000000.0
    },
    "2023-06-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.4,
        "Normalized EBITDA": 2800000.0,
        "Total Unusual Items": NaN,
        "Total Unusual Items Excluding Goodwill": NaN,
        "Net Income From Continuing Operation Net Minority Interest": -40000000.0,
        "Reconciled Depreciation": 19400000.0,
        "Reconciled Cost Of Revenue": 361000000.0,
        "EBIT": -16600000.0,
        "Net Interest Income": -7500000.0,
        "Interest Expense": 7500000.0,
        "Normalized Income": -40000000.0,
        "Net Income From Continuing And Discontinued Operation": -40000000.0,
        "Total Expenses": 476700000.0,
        "Total Operating Income As Reported": 100000.0,
        "Diluted Average Shares": 68289000.0,
        "Basic Average Shares": 68289000.0,
        "Diluted EPS": -0.59,
        "Basic EPS": -0.59,
        "Diluted NI Availto Com Stockholders": -40000000.0,
        "Net Income Common Stockholders": -40000000.0,
        "Net Income": -40000000.0,
        "Minority Interests": -500000.0,
        "Net Income Including Noncontrolling Interests": -39500000.0,
        "Net Income Continuous Operations": -39500000.0,
        "Tax Provision": 15400000.0,
        "Pretax Income": -24100000.0,
        "Other Income Expense": -16700000.0,
        "Other Non Operating Income Expenses": -16700000.0,
        "Special Income Charges": NaN,
        "Gain On Sale Of Business": NaN,
        "Gain On Sale Of Security": NaN,
        "Net Non Operating Interest Income Expense": -7500000.0,
        "Interest Expense Non Operating": 7500000.0,
        "Operating Income": 100000.0,
        "Operating Expense": 115700000.0,
        "Other Operating Expenses": NaN,
        "Research And Development": 5400000.0,
        "Selling General And Administration": 110300000.0,
        "Gross Profit": 115800000.0,
        "Cost Of Revenue": 361000000.0,
        "Total Revenue": 476800000.0,
        "Operating Revenue": 476800000.0
    }
}